John joined CMC Biologics in 2014 and serves as the Vice President for process development. Prior to joining CMC Biologics, he held director-level positions at Amgen focused on process development and characterization, clinical and commercial technology transfer, and process validation. John has a Ph.D. in chemical and biological engineering from the University of Wisconsin-Madison and